Nectar Lifescience Ltd
NSE: NECLIFE BSE: 532649
₹10.26
+0.12 (1.18%)
Fri, 06 Nov 2026, 09:24 am
Market Cap (in Cr)199.12
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KNectar Lifescience Financials
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.59B | 4.32B | 7.34B | 7.28B | 8.43B | 10.53B | 13.02B | 16.21B | 16.33B | 16.43B | 16.76B | 16.44B | 18.77B | 27.83B | 23.67B | 15.44B | 16.69B | 15.25B | 16.86B | 16.73B |
| Gross profit | 523.99M | 692.83M | 1.07B | 1.45B | 1.87B | 2.10B | 2.04B | 2.60B | 2.45B | 2.47B | 2.36B | 2.21B | 2.29B | 2.72B | 2.30B | 1.28B | 1.70B | 589.05M | 1.56B | -141.79M |
| Operating expenses (excl. COGS) | -1.78M | -3.49M | -4.35M | -345.20M | -296.27M | -317.34M | -360.95M | -462.33M | -410.20M | -573.00M | -533.79M | -567.91M | -551.21M | -688.35M | -689.98M | -766.46M | -680.52M | -630.03M | -625.55M | -729.72M |
| Selling/general/admin expenses, total | — | — | — | — | -296.27M | -310.01M | -343.08M | -453.28M | -394.29M | -573.00M | -532.37M | -567.91M | -551.21M | -682.16M | -671.64M | -744.93M | -658.66M | -609.53M | -604.65M | -683.77M |
| Research & development | — | — | — | — | — | — | — | — | — | — | -360.22M | -86.22M | -60.09M | — | — | -107.87M | -125.51M | -153.17M | -143.56M | -162.23M |
| Selling/general/admin expenses, other | — | — | — | — | -296.27M | -310.01M | -343.08M | -453.28M | -394.29M | -573.00M | -532.37M | -567.91M | -491.12M | -682.16M | -671.64M | -637.06M | -533.15M | -456.36M | -461.09M | -521.54M |
| Other operating expenses, total | -1.78M | -3.49M | -4.35M | -345.20M | 0 | -7.33M | -17.87M | -9.05M | -15.91M | 0 | -1.42M | 0 | 0 | -6.19M | -18.34M | -21.53M | -21.86M | -20.50M | -20.90M | -45.95M |
| Operating income | 522.21M | 689.34M | 1.07B | 1.11B | 1.57B | 1.78B | 1.68B | 2.14B | 2.04B | 1.90B | 1.83B | 1.64B | 1.74B | 2.03B | 1.61B | 511.30M | 1.02B | -40.98M | 937.42M | -871.51M |
| Non-operating income, total | -66.42M | -159.22M | -243.63M | -468.18M | -419.66M | -573.55M | -829.58M | -993.25M | -1.26B | -1.05B | -1.19B | -963.98M | -1.11B | -1.45B | -1.24B | -1.36B | -683.22M | -383.22M | -754.73M | -743.83M |
| Interest expense, net of interest capitalized | -98.93M | -207.57M | -273.72M | -496.15M | -603.02M | -420.98M | -1.03B | -1.15B | -1.38B | -1.26B | -1.23B | -1.17B | -1.15B | -1.46B | -1.19B | -1.04B | -792.78M | -696.09M | -773.92M | -660.51M |
| Interest capitalized | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 32.51M | 48.35M | 30.09M | 27.97M | 183.36M | -152.57M | 200.37M | 161.64M | 121.91M | 207.09M | 44.75M | 66.38M | 37.07M | 14.32M | -43.04M | -70.79M | 15.46M | 311.82M | 19.19M | -83.32M |
| Non-operating interest income | 13.08M | 23.56M | 11.55M | 28.16M | 13.53M | 9.30M | 128.93M | 160.39M | 116.26M | 158.42M | 56.31M | 67.90M | 52.22M | 59.59M | 27.02M | 26.82M | 18.83M | 17.26M | 123.90M | 14.89M |
| Miscellaneous non-operating expense | 19.43M | 24.79M | 18.54M | -190.00K | 169.83M | -161.87M | 71.44M | 1.25M | 5.65M | 48.67M | -11.81M | -1.77M | -15.40M | -45.27M | -70.06M | -97.61M | -3.37M | 294.56M | -104.71M | -98.21M |
| Unusual income/expense | — | — | — | — | — | — | — | — | — | — | — | 143.77M | 3.62M | 0 | 0 | -252.75M | 94.10M | 1.05M | 0 | 0 |
| Pretax income | 455.79M | 530.12M | 825.94M | 639.33M | 1.15B | 1.20B | 854.32M | 1.15B | 782.28M | 847.54M | 638.25M | 674.17M | 626.83M | 588.20M | 374.71M | -847.67M | 340.80M | -424.20M | 182.69M | -1.62B |
| Taxes | -75.90M | -62.84M | -78.55M | -109.59M | -230.10M | -173.47M | -122.16M | -290.09M | -161.42M | -184.90M | -95.85M | -120.79M | -104.11M | -112.20M | -56.82M | 115.03M | -90.34M | 182.37M | -132.74M | 478.53M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | -15.43M | — | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 379.89M | 451.85M | 747.39M | 529.74M | 922.89M | 1.03B | 732.16M | 857.42M | 620.86M | 662.64M | 542.40M | 553.38M | 522.72M | 476.00M | 317.89M | -732.64M | 250.46M | -241.83M | 49.95M | -1.14B |
| Net income | 379.89M | 451.85M | 747.39M | 529.74M | 922.89M | 1.03B | 732.16M | 857.42M | 620.86M | 662.64M | 542.40M | 553.38M | 522.72M | 476.00M | 317.89M | -732.64M | 250.46M | -241.83M | 49.95M | -1.14B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 379.89M | 451.85M | 747.39M | 529.74M | 922.89M | 1.03B | 732.16M | 857.42M | 620.86M | 662.64M | 542.40M | 553.38M | 522.72M | 476.00M | 317.89M | -732.64M | 250.46M | -241.83M | 49.95M | -1.14B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 608.78M | 808.27M | 1.27B | 1.41B | 1.96B | 2.24B | 2.29B | 2.90B | 2.88B | 2.66B | 2.40B | 2.26B | 2.38B | 2.67B | 2.22B | 1.11B | 1.59B | 550.21M | 1.54B | -247.62M |
| EBIT | 522.21M | 689.34M | 1.07B | 1.11B | 1.57B | 1.78B | 1.68B | 2.14B | 2.04B | 1.90B | 1.83B | 1.64B | 1.74B | 2.03B | 1.61B | 511.30M | 1.02B | -40.98M | 937.42M | -871.51M |
| Total operating expenses | -2.07B | -3.63B | -6.27B | -6.17B | -6.86B | -8.76B | -11.34B | -14.07B | -14.29B | -14.53B | -14.93B | -14.80B | -17.03B | -25.79B | -22.06B | -14.93B | -15.66B | -15.29B | -15.92B | -17.60B |
| Prepaid expenses | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Deferred income, current | — | — | — | — | — | — | — | — | 59.04M | 88.99M | 46.11M | 65.73M | 110.66M | 96.23M | 105.65M | 67.12M | 72.53M | 64.99M | 123.33M | 57.96M |
| Capital and operating lease obligations | 6.37M | 6.37M | 10.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 148.46M | 221.82M | 303.78M | 401.84M | 501.86M | 508.06M | 630.22M | 957.56M | 1.12B | 1.10B | 926.20M | 1.04B | 1.08B | 1.12B | 1.16B | 830.05M | — | — | — | — |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | 9.46M | 9.21M | 8.96M | 8.71M | 8.46M | 8.21M | 7.96M | 7.71M | 7.45M | 7.21M |
| Minority interest | 1.39M | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -25.90M | 0 | -29.77M | -60.90M | -53.29M | 0 | -22.43M | -22.43M | -22.43M | -22.43M | -27.04M | -26.99M | -13.50M | -13.50M | -13.54M | -11.21M | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
